消息

BALYO has announced that an addendum to its report dated January 6 2026, prepared by independent expert Ledouble, is now available on its website. The addendum follows the Autorité des marchés financiers (AMF) requests for clarifications made during its review of the tender offer and squeeze‑out that SoftBank Group initiated. Minority shareholders...

全文

Vitalik Buterin, co‑founder of Ethereum, has cautioned that prediction‑market platforms are shifting toward a “corposlop” model that prioritizes profit over consumer welfare. He attributes this trend to a heavy focus on short‑term price speculation and sports‑betting activities, which generate revenue during bear markets but erode market integrity....

全文

On Monday, Vanda Pharmaceuticals’ shares surged 33 % after the U.S. FDA approved Bysanti (milsaperidone) for treating bipolar I disorder and schizophrenia. Bysanti is the active metabolite of Fanapt (iloperidone) and has shown bioequivalence to the parent drug. The approval is seen as a turning point for Vanda, which had previously traded at a disc...

全文

National Vision (EYE) holds a Zacks Rank of #2 (Buy), reflecting strong earnings estimate revisions, while Hermes International SA – Unsponsored ADR (HESAY) carries a #4 (Sell) ranking. EYE’s forward price‑to‑earnings ratio is 30.39, notably lower than HESAY’s 45.24, indicating a less expensive valuation relative to expected earnings. The PEG ratio...

全文

Looking ahead, Tandem forecasts modest but profitable growth for 2026, projecting full‑year sales between $1.065 billion and $1.085 billion and gross margins of 56% to 57%. The company attributes its improving financials to a new pay‑as‑you‑go pharmacy model in the United States, which is shifting its revenue stream toward more predictable and high...

全文

Tandem Diabetes Care’s shares rose over 32% after the company released its fourth‑quarter earnings, which showed a 3% year‑over‑year revenue increase to $290 million. Worldwide insulin‑pump shipments reached 38,000 units, including 27,000 in the United States, reflecting the continued demand for its devices.

全文

The company’s fundamentals remain solid, with a 4 % dividend yield and expected revenue growth of 1.78 % next year. Investor sentiment is positive, with 439 Motley Fool followers and 15,600 Seeking Alpha users rating HST “Strong Buy.” Short interest is low at 4.20 % of the float, 3.06 days to cover.

全文

Host Hotels & Resorts (HST) has reached a new 52‑week high, with shares up 20.64 % over the past year. The stock has recorded 10 new highs and displays strong technical momentum, shown by a 100 % “Buy” rating from Barchart, a Weighted Alpha of +32.21, and a Trend Seeker “Buy” signal. The RSI sits at 65.77, indicating support near $19.65. Analysts a...

全文

Fusion Fuel Green PLC (NASDAQ: HTOO) has signed a definitive agreement to acquire a controlling interest in Royal Uranium Inc., which holds a diversified portfolio of nineteen uranium and natural‑gas royalties. The portfolio includes sixteen uranium royalties and three natural‑gas royalties operated by industry leaders such as Cameco and IsoEnergy....

全文

In healthcare and longevity, capAI’s subsidiary capMedical Inc. is evaluating AI‑enabled preventative health initiatives through a capital‑light operating model. The firm employs a lean “tiny teams” framework to maximize operating leverage, reduce fixed overhead, and accelerate platform development, thereby aligning disciplined capital allocation w...

全文